http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/list Mynewsdesk nyhetsfeed direkt från källan http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/list http://www.mynewsdesk.com/images/redesign/graphics/logos/logo-small.png 128 23 sv 15 Tue, 07 May 2013 15:23:00 +0200 Vid årsskiftet flyttade Recopharma och NovaHep in på våning 8 i Biotechhuset i Göteborg. Företagen hade tidigare lokaler i Novum, Huddinge men har nu flyttat verksamheten till Göteborg. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/nyinflyttade-life-science-bolag-i-biotechhuset-recopharma-och-novahep-58952?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/nyinflyttade-life-science-bolag-i-biotechhuset-recopharma-och-novahep-58952?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Mon, 18 Mar 2013 13:02:09 +0100 Inom Transplantation & Regenerative Medicine Laboratory står tiden aldrig still. Forskargruppen, som har sin verksamhet inom Sahlgrenska Science Park, har ett starkt framtidsfokus och BIO-X-projektet "Tissue-engineered vascular grafts for vascular replacement therapy" kan ytterligare befästa Göteborg som en klar föregångare inom regenerativ medicin med hjälp av stamceller. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/regenerativ-medicin-i-ropet-55956?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/regenerativ-medicin-i-ropet-55956?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Fri, 08 Mar 2013 14:15:00 +0100 Målet med BIO-X-projektet Unraveling stent är att förhindra ärrbildning i förträngda kärl. Med hjälp av smart textil och ny teknik kan en stickad stent snart repas upp och dras ut igen efter att den stabiliserat upp ett utvidgat blodkärl. Metoden har stor potential att påverka framtida behandling och stödet från BIO-X kan göra avsevärd skillnad. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/bio-x-en-spraangbraeda-foer-stentutveckling-55387?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/bio-x-en-spraangbraeda-foer-stentutveckling-55387?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Thu, 31 Jan 2013 14:32:37 +0100 Programmet för ”The 2nd World Congress on Surgical Training” den 17-19 juni 2013, även kallad Surgicon, har precis offentliggjorts. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/vaerldskongress-i-kirurgi-aeger-rum-i-goeteborg-i-juni-2013-53262?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/vaerldskongress-i-kirurgi-aeger-rum-i-goeteborg-i-juni-2013-53262?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Wed, 23 Jan 2013 15:05:00 +0100 In May 2012, GöteborgBIO opened the call for proposals ”Meeting the needs in the area of Cardiovascular and Metabolic diseases”. Now, three projects have been selected to achieve support for further development of their projects. Increased quality of life and reduced costs for society are common denominators for the new solutions which can imply essential improvements in healthcare and treatment. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/bio-x-projects-in-region-vaestra-goetaland-now-selected-52793?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/bio-x-projects-in-region-vaestra-goetaland-now-selected-52793?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Wed, 28 Nov 2012 13:17:15 +0100 On 5 December 2012, representatives from 12 of Sweden's most innovative Life Science companies will travel to Paris looking for French partners within oncology. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/swedish-life-science-stars-to-paris-hunting-for-prominent-french-oncology-partners-50271?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/swedish-life-science-stars-to-paris-hunting-for-prominent-french-oncology-partners-50271?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Fri, 23 Nov 2012 14:42:00 +0100 When ViroPharma Inc. invested in a Swedish medical innovation in 2011, the US company decided to locate its Nordic regional office at Sahlgrenska Science Park in Gothenburg. Since its establishment in June, ViroPharma Sweden AB has expanded rapidly and further recruitments to add to the company's existing six employees are anticipated. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/growth-is-on-the-agenda-for-viropharma-sweden-50068?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/growth-is-on-the-agenda-for-viropharma-sweden-50068?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Fri, 23 Nov 2012 09:24:00 +0100 När ViroPharma Inc. 2011 investerade i en svensk, medicinsk innovation valde det amerikanska bolaget att satsa på nordisk verksamhet med regionkontor på Sahlgrenska Science Park i Göteborg. Sedan starten i juni har ViroPharma Sweden AB vuxit snabbt och dagens sex anställda förväntas snart bli fler. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/goeteborgbio-intervju-med-roger-johansson-viropharma-50015?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/goeteborgbio-intervju-med-roger-johansson-viropharma-50015?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Thu, 08 Nov 2012 12:09:20 +0100 The “Silver Ear 2012" award has gone to Bo Håkansson, professor at the Department of Signals and Systems at Chalmers University of Technology in Gothenburg. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/bone-anchored-hearing-aids-praised-in-gothenburg-49173?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/bone-anchored-hearing-aids-praised-in-gothenburg-49173?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Wed, 24 Oct 2012 17:28:00 +0200 The recent BIO-X™ call for proposals “Meeting the needs in the area of Cardiovascular and Metabolic diseases" generated totally 14 project proposals from leading research teams. All proposals address needs for new innovative tools and methods for prevention, diagnosis or treatment. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/new-opportunities-for-industrial-and-clinical-partners-in-the-area-of-cardiovascular-and-metabolic-diseases-48316?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/new-opportunities-for-industrial-and-clinical-partners-in-the-area-of-cardiovascular-and-metabolic-diseases-48316?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Mon, 08 Oct 2012 11:21:06 +0200 The region of Västra Götaland has powerful innovative strength. Claes Lindahl, CEO and founder of Intellego Technologies, can now refer to himself as the "innovator of the future" following the recent nomination, when "SKAPA Framtidens Innovatör 2012 i Västra Götaland" was highlighted during an event in Gothenburg. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/innovator-of-the-future-claes-lindahl-ceo-and-founder-of-intellego-technologies-47302?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/innovator-of-the-future-claes-lindahl-ceo-and-founder-of-intellego-technologies-47302?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Thu, 04 Oct 2012 11:53:22 +0200 A driven team of people at Chalmers University of Technology is now taking part in a synthetic biology competition for students, competing against 190 teams from all over the world. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/chalmers-gothenburg-in-international-biosensor-competition-47148?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/chalmers-gothenburg-in-international-biosensor-competition-47148?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Fri, 28 Sep 2012 12:54:00 +0200 Seventeen Swedish life science organizations have joined forces to market Sweden Life Science Investment Year 2013. A year of exposure for partners and partnerships in the areas of pharmaceuticals, biotechnology, diagnostics and medical technology. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/goeteborgbio-part-of-sweden-life-science-investment-year-2013-46795?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/goeteborgbio-part-of-sweden-life-science-investment-year-2013-46795?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Fri, 28 Sep 2012 12:12:45 +0200 BIO-X was recently announced in the Västra Götaland region; a process which will open up completely new paths for researchers in Western Sweden. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/major-interest-in-bio-x-46793?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/major-interest-in-bio-x-46793?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Thu, 20 Sep 2012 12:10:00 +0200 Isofol Medical AB has announced that the the first patient in its randomized phase I/II trial, ISO-CC-002, has been enrolled. The study will evaluate pharmacokinetic and pharmacodynamic parameters of Isofol Medical’s lead candidate Modufolin® in patients with diagnosed with colon cancer. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/first-patient-enrolled-in-isofol-medical-s-iso-cc-002-trial-46314?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/first-patient-enrolled-in-isofol-medical-s-iso-cc-002-trial-46314?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Thu, 20 Sep 2012 11:18:48 +0200 Surgicon Congress 2013 – the 2nd World Congress on Surgical Training – går idag ut med sitt 2nd Announcement med det övergripande programinnehållet och listan över de världsberömda föreläsare/kirurger som hittills accepterat inbjudan att tala på Svenska Mässan i Göteborg den 17-19 juni 2013. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/vaerldsberoemda-kirurger-foerelaeser-i-goeteborg-i-juni-2013-46296?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/vaerldsberoemda-kirurger-foerelaeser-i-goeteborg-i-juni-2013-46296?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Wed, 19 Sep 2012 10:17:00 +0200 Mikael Kubista, the man who runs gene technology company TATAA Biocenter AB, has been named Western Pioneer of the Year. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/mikael-kubista-western-pioneer-of-the-year-46211?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/mikael-kubista-western-pioneer-of-the-year-46211?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Mon, 17 Sep 2012 14:58:00 +0200 Six researchers are set to receive a total of SEK 150 million from the Swedish Foundation for Strategic Research, SSF, for their innovative research into nanotechnology and materials technology. Of these researchers, two are from Chalmers University of Technology. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/sek-150-million-for-nanoresearchers-46091?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/sek-150-million-for-nanoresearchers-46091?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Fri, 14 Sep 2012 14:27:49 +0200 “Fou-Kortet “is aimed at improving the opportunities for small and medium-sized companies to compete in global markets, improving knowledge transfer between companies, academia and research institutions and creating new jobs. The programme is owned and run by Region Västra Götaland and contains two types of grants companies can apply for. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/research-and-development-to-improve-sme-s-in-vaestra-goetaland-45975?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/research-and-development-to-improve-sme-s-in-vaestra-goetaland-45975?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO Tue, 04 Sep 2012 09:44:28 +0200 The expansive Swedish Gothenburg-based pharmaceutical company ABIGO Medical AB is benefiting from the debate concerning bacteria. In order to meet demand, SEK 10 million is being invested in the second half of 2012. http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/business-is-good-for-abigo-medical-ab-45276?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news http://www.mynewsdesk.com/se/pressroom/goteborgbio/news/view/business-is-good-for-abigo-medical-ab-45276?utm_source=rss&utm_medium=rss&utm_campaign=Subscription&utm_content=news GöteborgBIO